These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10935673)

  • 1. Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience.
    Pacher R; Stanek B
    Eur J Heart Fail; 1999 Aug; 1(3):263-8. PubMed ID: 10935673
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous milrinone: therapeutic responses in heart failure.
    Braunwald E
    Am Heart J; 1991 Jun; 121(6 Pt 2):1937-8. PubMed ID: 2035423
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous therapy for advanced heart failure.
    Stanek B; Pacher R
    Curr Opin Cardiol; 2000 May; 15(3):156-60. PubMed ID: 10952421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
    Curley M; Liebers J; Maynard R
    J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
    Opasich C; Russo A; Mingrone R; Zambelli M; Tavazzi L
    Eur J Heart Fail; 2000 Mar; 2(1):7-11. PubMed ID: 10742697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological treatment of heart failure].
    Kohno M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():660-6. PubMed ID: 12735047
    [No Abstract]   [Full Text] [Related]  

  • 7. Present status of various inotropic agents in heart failure.
    Mittal SR; Maheshwari N
    J Assoc Physicians India; 2001 Nov; 49():1095-9. PubMed ID: 11868865
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous heart failure medications: an update for home health clinicians.
    Sherrod MM; Graulty R; Crawford M; Cheek DJ
    Home Healthc Nurse; 2009; 27(10):610-9; quiz 620-1. PubMed ID: 19907237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
    Palmerini E; Söderberg S; Mondillo S; Favilli R; Lunghetti S
    Acute Card Care; 2015 Mar; 17(1):14-9. PubMed ID: 25806830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amrinone: an advance or a wrong step?
    Franciosa JA
    Ann Intern Med; 1985 Mar; 102(3):399-400. PubMed ID: 3970477
    [No Abstract]   [Full Text] [Related]  

  • 11. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
    Gorski LA
    Home Healthc Nurse; 2002 Apr; 20(4):244-53; quiz 253-4. PubMed ID: 11984193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infusion therapy at outpatient clinic in chronic end-stage heart failure].
    Nishi K; Sato Y; Miyamoto T; Taniguchi R; Matsuoka T; Kuwabara Y; Isoda K; Yamane K; Hatakenaka T; Fujinaga K; Fujiwara H; Takatsu Y
    J Cardiol; 2007 May; 49(5):251-8. PubMed ID: 17552290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion therapy in severe heart failure. A reappraisal.
    Campana C; Scelsi L; Serio A
    Ital Heart J; 2003 May; 4 Suppl 2():15S-21S. PubMed ID: 14635365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inotropic agents in advanced and refractory heart failure].
    Mangiavacchi M; Gronda E
    Ital Heart J Suppl; 2003 Jan; 4(1):3-7. PubMed ID: 12690928
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydralazine and nitrates: beyond race and ethnicity.
    Ghali JK
    J Card Fail; 2007 Apr; 13(3):238. PubMed ID: 17448423
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
    Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
    Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of chronic cardiac decompensation].
    van Zanten RA; Laird-Meeter K
    Ned Tijdschr Geneeskd; 1987 Apr; 131(15):615-8. PubMed ID: 3574530
    [No Abstract]   [Full Text] [Related]  

  • 20. [New oral drugs for the treatment of congestive heart failure].
    Hayashida W; Kumada T; Kawai C
    Nihon Rinsho; 1992 Feb; 50(2):413-9. PubMed ID: 1319514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.